l-carnitine injectable vs oral l carnitine injection L- Carnitine Injection – Clinica IDEAL Harwin Differential effects of oral and
Description
M.CampisiJ.et al
DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage
Conversely, ACSL4 expression, along with levels of ROS, MDA, 4-HNE, Fe 2+ , and -synuclein, were markedly elevated, thereby exacerbating ferroptosis and lipid peroxidation in the brain
The combined histopathological and biochemical evidence strongly supports the clinical translatability of this targeted protein degradation platform
